Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies1000
RedShift BioAnalytics
RedShiftBio revolutionizes protein characterization for biopharmaceutical development with advanced infrared technology.
Sector
Subsector
Location
total rounds
total raised
Protein Dynamic Solutions
PDS provides a biotechnology platform for real-time monitoring of proteins in solution.
Sector
Subsector
Keywords
Location
total rounds
total raised
IonDX
IonDX is a bioanalytical instrumentation company that commercializes an advanced system to analyze biologic drugs.
Sector
Subsector
Location
total rounds
total raised
Andson Biotech
Andson Biotechnology develops advanced analytics for biopharmaceutical workflows.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds7
Number of Funding Rounds
Money Raised
Their latest funding was raised on 06.02.2020. Their latest investor National Science Foundation. Their latest round Series B
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors5
Number of lead investors
Number of investors
National Science Foundation
The National Science Foundation (NSF) is an independent federal agency that funds scientific research and education in the United States.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Genoa Ventures
Genoa Ventures invests in early-stage life sciences technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders2
Erik Gentalen
Erik is the inventor of Intabio’s microfluidic-based innovations, and is responsible for advancing the technology and the overall development of the BlazeTM system. Erik has spent over 16 years developing microfluidic tools for the analysis of proteins and nucleic acids. Prior to Intabio, Erik was the Director of Systems Integration at ProteinSimple where he led the R&D team developing the Simple Western capillary immunoassay from invention to launch, and also led product support for the iCE3 capillary-based IEF system. Prior to ProteinSimple, he was the Program Manager at Caliper Life Sciences, where he led the system integration for a microfluidic research system, developed chip designs for customer applications, and managed application development collaborations with pharmaceutical partners. Erik was also an early employee at Affymetrix and Combimatrix, where his responsibilities included designing instrumentation, developing synthesis methods, managing the DNA array production facility, and collaborating on novel array applications. Erik is also a registered patent agent.
current job
organization founded
Erik Gentalen
Lena Wu
Lena is responsible for the company’s financing, corporate and business development strategy and execution. She was previously the CEO, President and co-founder of Rogne Biosciences, a therapeutic dermatology company. Lena has extensive management experience in companies developing and commercializing microfluidic-based products. She was the Vice-President of Corporate Development of On-Q-ity, a microfluidic-based, cancer diagnostic device company, and was also the Director of Business Development at Caliper Technologies, a microfluidic platform company developing analytical instrumentation systems for life science and diagnostic markets. Lena has 20 years of industry experience, and has advanced the strategic objectives as an operational business consultant for emerging companies across therapeutic, diagnostic and life science sectors. She began her business career at Millennium Pharmaceuticals, following a post-doc in yeast genetics at Harvard.
current job
organization founded
Lena Wu